Growth hormone replacement therapy safety and effectiveness study
Treatments studied
Part of Bones, joints & muscles, Brain & nervous system, Hormones & metabolism clinical trials.
This study tests a new injectable growth hormone treatment for adults whose bodies don't produce enough growth hormone naturally. Researchers will measure how safe it is, how your body processes it, and whether it helps you feel better and function more normally.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man aged 18–79 years old
- Your blood tests confirm you have adult growth hormone deficiency (low growth hormone or IGF-1 levels)
- You haven't received growth hormone treatment in the past 6 months
- If you take other hormone replacement therapy, it must have been at a stable dose for at least 3 months
- Your liver and kidney function are normal or only mildly abnormal
- You have no active cancer, history of cancer, or suspicious thyroid or lung nodules
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new growth hormone treatment called GenSci134 in healthy adults and adults with growth hormone deficiency (AGHD). The goal is to see if it is safe and effective for people who need growth hormone replacement.
This study tests an experimental growth hormone (Inpegsomatropin) to help children born small for gestational age who remain short. If your child meets the specific height, age, and puberty criteria, they may qualify.
This trial tests if a long-acting growth hormone (PEGylated GH) helps children with various causes of short stature grow taller. It may be an option if your child has a condition like growth hormone deficiency, Turner syndrome, or idiopathic short stature.
This study tests a new growth hormone injection (Inpegsomatropin) to help children with idiopathic short stature (short stature with no known cause) grow taller. It may be an option if your child is very short compared to peers and has not started puberty.
This study tests a new growth hormone treatment called GenSci134 for children who have not yet gone through puberty and are not growing because their bodies do not make enough growth hormone. The goal is to see if the medicine helps them grow taller.
This study tests whether a new long-acting growth hormone injection helps girls with Turner syndrome grow taller. Turner syndrome is a genetic condition that affects growth, and this trial will see if this treatment is safe and effective.
Hear when a new Adult Growth Hormone Deficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.